Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

The gut bacterium Akkermansia muciniphila has been increasingly recognized for its therapeutic potential in treating metabolic disorders, including obesity, diabetes, and metabolicdysfunction-associated fatty liver disease (MAFLD). However, its underlying mechanism involved in its well-known metabol...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut Microbes
Hlavní autoři: Rao, Yong, Kuang, Zhiqi, Li, Chan, Guo, Shiyao, Xu, Yaohao, Zhao, Dandan, Hu, Yutao, Song, Bingbing, Jiang, Zhi, Ge, Zhenhuang, Liu, Xiyuan, Li, Chengdao, Chen, Shuobin, Ye, Jiming, Huang, Zhishu, Lu, Yongjun
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2021
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8158032/
https://ncbi.nlm.nih.gov/pubmed/34030573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19490976.2021.1927633
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky